Notes
Journal of Natural Products, 2005, Vol. 68, No. 8 1299
electrospray ionization. A Chromatotron 8924 (Harrison Re-
search, Palo Alto, CA) with silica gel 60 PF 254 (1 mm) plates
was used. TLC analysis was carried out on precoated silica
gel G254 or aluminum oxide ALOX-100 UV254 500 µm plates
with visualization by 5% H2SO4 in EtOH and heating with
Dragendorff’s reagent. Single-crystal-X-ray diffraction mea-
surements were made on a Nonius Kappa CCD diffractometer
with Mo KR radiation.
Plant Material. Leaves of Z. syncarpum Tul. were identi-
fied and collected in Lara State, Venezuela, by one of the
authors (C.L.B.) in February 2002. A voucher specimen, BUR
230202 (1), is deposited at the private herbarium of this author
(518 Audubon, Oxford, MS 38655, e-mail: in_the_200@
mail2farm.com).
Extraction and Isolation. The air-dried and powdered
leaves Z. syncarpum (412 g) were extracted with MeOH at
room temperature. The extract was concentrated under re-
duced pressure to yield 80 g of residue. The methanol extract
(80 g) was subjected to silica gel vacuum liquid chromatogra-
phy (750 g of silica gel, 5.25 µm) and eluted beginning with
n-hexane (100%), n-hexane-chloroform (1:1), chloroform (100%),
and finally ethyl acetate-methanol (10%-100%). Altogether,
25 major fractions (250 mL each) were collected, and the
elution was monitored by TLC.
Fractions 9-17 (6.5 g) were combined and passed over
another silica gel column (250 g), eluted with chloroform-ethyl
acetate (25%-100%), followed by step gradient elution with
ethyl acetate-methanol (10%-100%). In total, 20 fractions
were collected. 3-Methoxyaegeline (1, 30 mg), from fraction 8,
was obtained by recrystallization of an ethyl acetate-methanol
mixture at room temperature. Fraction 17 (3.5 g) was further
chromatographed over an alumina column (38 × 39 cm; 350 g
basic alumina, Sigma-Aldrich) and eluted with chloroform
(100%) and chloroform-methanol (2% to 25%). A total of 17
fractions were collected and were divided into three groups:
group A (1), group B (2-4), and group C (5-17). Group B
(fractions 2-4, 0.9 g) was further fractionated by silica gel
chromatography with chloroform-methanol (0.5%-20%) to
afford 3-methoxy-7-acetylaegeline (2, 28 mg) and 3-methoxy-
7-cinnamoylaegeline (3, 54 mg). Group C (fractions 5-17, 1.4
g) was further purified using the Chromatotron (hexane-
CHCl3-MeOH, 1:92.5:6.5), followed by recrystallization in
ethyl acetate-methanol, to obtain an additional quantity of
3-methoxyaegeline (1, 355 mg).
Conversion of Compound 1 to 2. Treatment of 1 (10 mg)
with acetic anhydride (250 µL) and pyridine (250 µL) at room
temperature for 4 days and subsequent workup gave 2 (8 mg),
with 1H NMR and 13C NMR data identical to natural com-
pound 2.
3-Methoxy-7-cinnamoylaegeline (3): light yellow, amor-
25
phous powder; [R]D 0° (c 0.13, CHCl3); UV (MeOH) λmax 242
(4.83), 252 (4.69), 278 (4.94) nm; IR (KBr) νmax 3472, 2961,
2923, 1713, 1604, 1449, 1268, 757 cm-1; NMR data, see Table
1; HRMS m/z 480.1821 (calcd for C28H27NO5, [M + Na]+,
480.1787).
Evaluation of in Vitro Antiparasitic and Anti-infective
Activities. Antimalarial activity of the compounds was de-
termined in vitro on chloroquine-sensitive (D6, Sierra Leone)
and -resistant (W2, Indochina) strains of P. falciparum. This
96-well microplate assay is based on evaluation of the effect
of the compounds on the growth of asynchronous cultures of
P. falciparum, determined by the evaluation of parasite lactate
dehydrogenase (pLDH) activity.17 The appropriate dilutions
of the compounds were prepared in RPMI 1640 medium and
added to the cultures of P. falciparum (2% hematocrit, 2%
parasitemia) set up in clear flat-bottomed 96-well plates. The
plates were placed in a modular incubation chamber, flushed
with a gaseous mixture of 90% N2, 5% CO2, and 5% O2, and
incubated at 37 °C for 48 h. Growth of the parasite in each
well was determined by the pLDH assay using Malstat
reagent. The medium and RBC controls were included on each
plate. The standard antimalarial agents, chloroquine and
artemisinin, were used as the positive controls, while DMSO
was tested as the negative control.
Acknowledgment. We thank F. T. Wiggers and C. D.
Dunbar, National Center for Natural Products Research, for
NMR and MS, and S. C. Sanders and B. G. Smiley, National
Center for Natural Products Research, for the antimalarial
bioassays.
References and Notes
(1) Zomlefer, W. B. In Guide to Flowering Plant Families; University of
North Carolina Press: Chapel Hill, NC, 1994; pp 145-148.
(2) Burrows, G. E.; Tyel, R. J. Toxic Plants of North America; Iowa State
University Press: Ames, IA, 2001; pp 1082-1085.
(3) Millspaugh, C. F. American Medicinal Plants; Dover Publications
Inc.: New York, 1974; pp 124-128.
(4) Talapatra, S. K.; Dutta, S.; Talapatra, B. B. Phytochemistry 1973,
12, 729-730.
(5) The Wealth of India: Raw Materials; PID, Council of Scientific and
Industrial Research (CSIR): New Delhi, 1976; Vol. II, pp 18-19.
(6) Stone, B. C. In A Revised Handbook to the Flora of Ceylon; Dassan-
ayake, M. D., Fosberg, R., Eds.; Oxford and IBH Publishing: New
Delhi, 1985; Vol. 5, p 406.
(7) Jayaweera, D. M. A. In Medicinal Plants Used in Sri Lanka; National
Science Council: Sri Lanka, 1982; Part 5, p 39.
(8) Weenen, H.; Nkunya, M. H. H.; Bray, D. H.; Mwasumbi, L. B.; Kinabo,
L. S.; Kilimali, V. A.; Wijnberg, J. B. Planta Med. 1990, 56, 371-
373.
(9) Kalia, N. K.; Sing, B.; Sood, R. P. J. Nat. Prod. 1999, 62, 311-312.
(10) Reyes, B.; Navarrete, A.; Sixtos, C.; Aguirre, E.; Jimenez, S.; Estrada,
E. Rev. Mex. Cienc. Farm. 1991, 21, 30-34.
(11) Ross, S. A.; Krishnaveni, K. S.; Satoshi, T.; Burandt, C. L.; Elsohly,
M. A. Phytother. Res. 2005 (communicated).
(12) Ross, S. A.; Sultana, G. N.; Burandt, C. L.; ElSohly, M. A.; Marais,
J. P. J.; Ferreira, D. J. Nat. Prod. 2004, 67, 88-90.
(13) De Morais, S. M.; Facundo, V. A.; Braz Filho, R. J. Essent. Oil Res.
2002, 14, 274-275.
(14) Facundo, V. A.; De Morais, S. M.; Machado, M. I. L.; Matos, F. J. de
A.; Da Frota, L. C. M. J. Essent. Oil. Res. 1999, 11, 426-428.
(15) Facundo, V. A.; De Morais, S. M.; Braz Filho, R.; Matos, I. J. de A;
Souza, R. T. Rev. Bras. Farm. 1997, 78, 57-59.
(16) Swinehart, J. A.; Stermitz, F. R. Phytochemistry 1980, 19, 1219-
1223.
(17) Makler, M. T.; Ries J. M.; Williams J. A.; Bancroft J. E.; Piper R. C.;
Gibbins B. L.; Hinriches D. J. Am. J. Trop. Med. Hyg. 1993, 48,
739-741.
3-Methoxyaegeline (1): white crystals (EtOAc-MeOH),
mp 138-139 °C, [R]D25 0° (c 0.11, CHCl3); UV (EtOH) λmax (log
ꢀ) 218 (4.37), 225 (4.57), 278 (4.65) nm; IR (KBr) νmax 3337,
2920, 2851, 2358, 2339, 1713, 1656, 1615, 1540, 1516, 1451,
1261, 1231, 1027, 977 cm-1; NMR data, see Table 1; HRMS
m/z 328.1546 (calcd for C19H21NO4, [M + H]+, 328.1543).
X-ray Crystal Structure Determination of 1. A suitable
crystal of 1 was obtained by slow crystallization from EtOAc-
MeOH (1:1) at room temperature for 3 days. Crystal data:
C19H21NO4, monoclinic space group P21, a ) 11.684(3) Å, b )
9.293(2) Å, c ) 15.710(5) Å, â ) 102.586(10)°, V ) 1664.8(8)
Å3, Z ) 4, R ) 0.048 (F2>2σ), Rw ) 0.103 (all F2) for 5335
unique data having 2θ < 61° and 450 refined parameters.
Crystallographic data for the structure reported in this paper
have been deposited with the Cambridge Crystallographic
Data Centre and allocated the deposition number CCDC
274925. Copies of the data can be obtained, free of charge, on
application to the Director, CCDC, 12 Union Road, Cambridge
CB2 1EZ, UK (fax: +44-(0)1223-336033 or e-mail: deposit@
ccdc.cam.ac.uk).
3-Methoxy-7-acetylaegeline (2): light yellow, amorphous
25
powder; [R]D 0° (c 0.23, CHCl3); UV (MeOH) λmax (log ꢀ) 242
(4.82), 252 (4.67), 282 (4.98) nm; IR (KBr) νmax 3368, 3281,
2953, 1713, 1659, 1517, 1450, 1263, 1162, 1026, 975, 766 cm-1
;
NMR data, see Table 1; HRMS m/z 392.1462 (calcd for C21H23-
NO5, [M + Na]+, 392.1474).
NP0580558